Sharone Green MD
Title Associate Professor
Institution University of Massachusetts Medical School
Department Medicine
Division Infectious Diseases And Immunology
Address University of Massachusetts Medical School
55 Lake Avenue North
Worcester MA 01655
Telephone 508-856-4182
Email
Other Positions
Institution UMMS - Graduate School of Biomedical Sciences
Department Clinical Population Health Research

Institution UMMS - Graduate School of Biomedical Sciences
Department Immunology & Virology

Institution UMMS - Programs, Centers and Institutes
Department Center for Infectious Disease and Vaccine Research
Narrative

Academic Background

Education:

  • B.A., Queens College, 1983
  • M.D., Eastern Virginia Medical School, 1986

Post-Graduate Training:

  • Internal Medicine - Washington Hospital Center, 1986-89
  • Infectious Diseases - University of Massachusetts Medical Center, 1989-92
Photo: Sharone Green, MD

Research Interests

  • Immunopathogenesis of viral infections
  • Human T cell responses to flavivirus infections including dengue and West Nile virus
  • Human immune responses to novel viral vaccines

My laboratory studies T lymphocyte responses to viral infections and their role in protection as well as immunopathogenesis of disease. The study of T cell responses to natural viral infections can be utilized towards the development and testing of viral vaccines. Dengue virus, yellow fever virus, West Nile virus and Japanese encephalitis viruses are the current model systems under study.

Dengue viruses

Dengue viruses, of which there are four serotypes, are transmitted from human-to-human by mosquitoes in tropical and subtropical regions of the world. In some individuals, dengue virus infections manifest as dengue hemorrhagic fever (DHF), which is characterized by plasma leakage, and can lead to life-threatening shock. Our laboratory hypothesizes that DHF is an example of immunopathology caused by the ‘over’ responses of memory T cells. The role of other arms of the adaptive immune system in regulating disease severity, such as pre-existing antibodies that mediate neutralization, enhancement and antibody-dependent cell cytotoxicity (ADCC) are also under investigation. As part of an ongoing multi-center international NIH-funded Program Project, I spent over 4 years in Thailand trying to elucidate the role of immune activation in the development of plasma leakage in children with DHF. These field studies are currently ongoing and valuble samples from these children are utilized in our laboratory to address these immune mechanisms in disease pathogenesis.

West Nile virus

West Nile virus (WNV), another mosquito-borne virus which is rapidly emerging in the United States, often produces subclinical infection or an acute viral syndrome, West Nile fever. In a minority of infected people the infection causes neurological illness -l WNV encephalitis. CD8 + T cells can be demonstrated in the brains of individuals who have succumbed to WNV encephalitis. T cells likely play a role in protecting the host from neuroinvasion and once neuroinvasion has occurred, T cells may also play a role in disease pathogenesis. Studies are underway for detailed analysis of memory T cell responses in humans infected by WNV, including CTL responses and interferon gamma production by WNV-specific T cells using IFN-gamma ELISPOT and intracellular cytokine staining assays. In addition, we have established a murine model of WNV encephalitis to study the role of flavivirus cross-reactive T cells in protection from WNV illness as well as their role in disease pathogenesis.

Heterologous immunity to flaviviruses

Flaviviruses co-circulate in many parts of the world. Due to relatively conserved genomic sequences, the effect of pre-existing immunity to one flavivirus on host immune responses to a secondary flavivirus can vary. In the case of dengue viruses, secondary infection may lead to an increase in disease severity. Some human epidemiologic and animal model studies suggest that other combinations of flaviviruses may lead to protection from disease. My laboratory is investigating the role of pre-existent flavivirus cross-reactive T cell and antibody responses on epitope hierarchy, disease outcome and viral burden in murine models, including human HLA transgenic mice.

Novel vaccines

Novel vaccines, such as DNA vaccines and chimeric virus vaccines, may induce antibody and/or T cell memory in immunized individuals. My laboratory is actively involved in evaluating T cell responses to such novel vaccines in the hope of developing much needed first and second generation vaccines for the US and the developing world.

Publications
1. Srikiatkhachorn A, Wichit S, Gibbons RV, Green S, Libraty DH, Endy TP, Ennis FA, Kalayanarooj S, Rothman AL. Dengue viral RNA levels in peripheral blood mononuclear cells are associated with disease severity and preexisting dengue immune status. PLoS One. 2012; 7(12):e51335.
  View in: PubMed
 
2. Mathew A, West K, Kalayanarooj S, Gibbons RV, Srikiatkhachorn A, Green S, Libraty D, Jaiswal S, Rothman AL. B-cell responses during primary and secondary dengue virus infections in humans. J Infect Dis. 2011 Nov; 204(10):1514-22.
  View in: PubMed
 
3. Friberg H, Bashyam H, Toyosaki-Maeda T, Potts JA, Greenough T, Kalayanarooj S, Gibbons RV, Nisalak A, Srikiatkhachorn A, Green S, Stephens HA, Rothman AL, Mathew A. Cross-Reactivity and Expansion of Dengue-Specific T cells During Acute Primary and Secondary Infections in Humans. Sci Rep. 2011; 1:51.
  View in: PubMed
 
4. Smith HL, Monath TP, Pazoles P, Rothman AL, Casey DM, Terajima M, Ennis FA, Guirakhoo F, Green S. Development of Antigen-Specific Memory CD8+ T Cells Following Live-Attenuated Chimeric West Nile Virus Vaccination. J Infect Dis. 2011 Feb; 203(4):513-22.
  View in: PubMed
 
5. Green S, Ennis FA, Mathew A. Long term recall of memory CD8 T cells in mice to first and third generation smallpox vaccines. Vaccine. 2011 Feb 11; 29(8):1666-76.
  View in: PubMed
 
6. Potts JA, Thomas SJ, Srikiatkhachorn A, Supradish PO, Li W, Nisalak A, Nimmannitya S, Endy TP, Libraty DH, Gibbons RV, Green S, Rothman AL, Kalayanarooj S. Classification of dengue illness based on readily available laboratory data. Am J Trop Med Hyg. 2010 Oct; 83(4):781-8.
  View in: PubMed
 
7. Potts JA, Gibbons RV, Rothman AL, Srikiatkhachorn A, Thomas SJ, Supradish PO, Lemon SC, Libraty DH, Green S, Kalayanarooj S. Prediction of dengue disease severity among pediatric Thai patients using early clinical laboratory indicators. PLoS Negl Trop Dis. 2010; 4(8):e769.
  View in: PubMed
 
8. Singh R, Rothman AL, Potts J, Guirakhoo F, Ennis FA, Green S. Sequential immunization with heterologous chimeric flaviviruses induces broad-spectrum cross-reactive CD8+ T cell responses. J Infect Dis. 2010 Jul 15; 202(2):223-33.
  View in: PubMed
 
9. Trobaugh DW, Yang L, Ennis FA, Green S. Altered effector functions of virus-specific and virus cross-reactive CD8+ T cells in mice immunized with related flaviviruses. Eur J Immunol. 2010 May; 40(5):1315-27.
  View in: PubMed
 
10. Friberg H, Burns L, Woda M, Kalayanarooj S, Endy TP, Stephens HA, Green S, Rothman AL, Mathew A. Memory CD8(+) T cells from naturally acquired primary dengue virus infection are highly cross-reactive. Immunol Cell Biol. 2011 Jan; 89(1):122-9.
  View in: PubMed
 
11. Srikiatkhachorn A, Gibbons RV, Green S, Libraty DH, Thomas SJ, Endy TP, Vaughn DW, Nisalak A, Ennis FA, Rothman AL, Nimmannitaya S, Kalayanarooj S. Dengue hemorrhagic fever: the sensitivity and specificity of the world health organization definition for identification of severe cases of dengue in Thailand, 1994-2005. Clin Infect Dis. 2010 Apr 15; 50(8):1135-43.
  View in: PubMed
 
12. Srikiatkhachorn A, Green S. Markers of dengue disease severity. Curr Top Microbiol Immunol. 2010; 338:67-82.
  View in: PubMed
 
13. Mathew A, O'Bryan J, Marshall W, Kotwal GJ, Terajima M, Green S, Rothman AL, Ennis FA. Robust intrapulmonary CD8 T cell responses and protection with an attenuated N1L deleted vaccinia virus. PLoS One. 2008; 3(10):e3323.
  View in: PubMed
 
14. Wang S, Kennedy JS, West K, Montefiori DC, Coley S, Lawrence J, Shen S, Green S, Rothman AL, Ennis FA, Arthos J, Pal R, Markham P, Lu S. Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers. Vaccine. 2008 Jul 23; 26(31):3947-57.
  View in: PubMed
 
15. Kennedy JS, Co M, Green S, Longtine K, Longtine J, O'Neill MA, Adams JP, Rothman AL, Yu Q, Johnson-Leva R, Pal R, Wang S, Lu S, Markham P. The safety and tolerability of an HIV-1 DNA prime-protein boost vaccine (DP6-001) in healthy adult volunteers. Vaccine. 2008 Aug 18; 26(35):4420-4.
  View in: PubMed
 
16. Wang S, Kennedy JS, West K, Montefiori DC, Coley S, Lawrence J, Shen S, Green S, Rothman AL, Ennis FA, Arthos J, Pal R, Markham P, Lu S. Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers. Vaccine. 2008 Feb 20; 26(8):1098-110.
  View in: PubMed
 
17. Libraty DH, Myint KS, Murray CK, Gibbons RV, Mammen MP, Endy TP, Li W, Vaughn DW, Nisalak A, Kalayanarooj S, Hospenthal DR, Green S, Rothman AL, Ennis FA. A comparative study of leptospirosis and dengue in Thai children. PLoS Negl Trop Dis. 2007; 1(3):e111.
  View in: PubMed
 
18. Srikiatkhachorn A, Krautrachue A, Ratanaprakarn W, Wongtapradit L, Nithipanya N, Kalayanarooj S, Nisalak A, Thomas SJ, Gibbons RV, Mammen MP, Libraty DH, Ennis FA, Rothman AL, Green S. Natural history of plasma leakage in dengue hemorrhagic fever: a serial ultrasonographic study. Pediatr Infect Dis J. 2007 Apr; 26(4):283-90; discussion 291-2.
  View in: PubMed
 
19. Laoprasopwattana K, Libraty DH, Endy TP, Nisalak A, Chunsuttiwat S, Ennis FA, Rothman AL, Green S. Antibody-dependent cellular cytotoxicity mediated by plasma obtained before secondary dengue virus infections: potential involvement in early control of viral replication. J Infect Dis. 2007 Apr 15; 195(8):1108-16.
  View in: PubMed
 
20. Srikiatkhachorn A, Ajariyakhajorn C, Endy TP, Kalayanarooj S, Libraty DH, Green S, Ennis FA, Rothman AL. Virus-induced decline in soluble vascular endothelial growth receptor 2 is associated with plasma leakage in dengue hemorrhagic Fever. J Virol. 2007 Feb; 81(4):1592-600.
  View in: PubMed
 
21. Green S, Rothman A. Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr Opin Infect Dis. 2006 Oct; 19(5):429-36.
  View in: PubMed
 
22. Bashyam HS, Green S, Rothman AL. Dengue virus-reactive CD8+ T cells display quantitative and qualitative differences in their response to variant epitopes of heterologous viral serotypes. J Immunol. 2006 Mar 1; 176(5):2817-24.
  View in: PubMed
 
23. Laoprasopwattana K, Libraty DH, Endy TP, Nisalak A, Chunsuttiwat S, Vaughn DW, Reed G, Ennis FA, Rothman AL, Green S. Dengue Virus (DV) enhancing antibody activity in preillness plasma does not predict subsequent disease severity or viremia in secondary DV infection. J Infect Dis. 2005 Aug 1; 192(3):510-9.
  View in: PubMed
 
24. Mathew A, Terajima M, West K, Green S, Rothman AL, Ennis FA, Kennedy JS. Identification of murine poxvirus-specific CD8+ CTL epitopes with distinct functional profiles. J Immunol. 2005 Feb 15; 174(4):2212-9.
  View in: PubMed
 
25. Libraty DH, Young PR, Pickering D, Endy TP, Kalayanarooj S, Green S, Vaughn DW, Nisalak A, Ennis FA, Rothman AL. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J Infect Dis. 2002 Oct 15; 186(8):1165-8.
  View in: PubMed
 
26. Zivna I, Green S, Vaughn DW, Kalayanarooj S, Stephens HA, Chandanayingyong D, Nisalak A, Ennis FA, Rothman AL. T cell responses to an HLA-B*07-restricted epitope on the dengue NS3 protein correlate with disease severity. J Immunol. 2002 Jun 1; 168(11):5959-65.
  View in: PubMed
 
27. Mangada MM, Endy TP, Nisalak A, Chunsuttiwat S, Vaughn DW, Libraty DH, Green S, Ennis FA, Rothman AL. Dengue-specific T cell responses in peripheral blood mononuclear cells obtained prior to secondary dengue virus infections in Thai schoolchildren. J Infect Dis. 2002 Jun 15; 185(12):1697-703.
  View in: PubMed
 
28. Libraty DH, Endy TP, Kalayanarooj S, Chansiriwongs W, Nisalak A, Green S, Ennis FA, Rothman AL. Assessment of body fluid compartment volumes by multifrequency bioelectrical impedance spectroscopy in children with dengue. Trans R Soc Trop Med Hyg. 2002 May-Jun; 96(3):295-9.
  View in: PubMed
 
29. Gagnon SJ, Mori M, Kurane I, Green S, Vaughn DW, Kalayanarooj S, Suntayakorn S, Ennis FA, Rothman AL. Cytokine gene expression and protein production in peripheral blood mononuclear cells of children with acute dengue virus infections. J Med Virol. 2002 May; 67(1):41-6.
  View in: PubMed
 
30. Libraty DH, Endy TP, Houng HS, Green S, Kalayanarooj S, Suntayakorn S, Chansiriwongs W, Vaughn DW, Nisalak A, Ennis FA, Rothman AL. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J Infect Dis. 2002 May 1; 185(9):1213-21.
  View in: PubMed
 
31. Green S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Suntayakorn S, Nisalak A, Rothman AL, Ennis FA. Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity. J Med Virol. 1999 Nov; 59(3):329-34.
  View in: PubMed
 
For assistance with using Profiles, please refer to the online tutorials or contact UMMS Help Desk or call 508-856-8643.
 
Keyword
Last Name
Institution
    
 
 
 
Keywords   
Dengue
Dengue Virus
Dengue Hemorrhagic Fever
Flavivirus Infections
CD8-Positive T-Lymphocytes
See all (165) keywords
Co-Authors  
Ennis, Francis
Libraty, Daniel
Lu, Shan
Mathew, Anuja
Srikiatkhachorn, Anon
See all (15) people
Physical Neighbors  
Mathew, Anuja
Bebinger, David
Co, Marydawn
Terajima, Masanori
Hatch, Steven

UMMS Home

Intranet

This is an official Page/Publication of the University of Massachusetts Worcester Campus
Office of the Vice Provost for Research, 55 Lake Ave North, Worcester, Massachusetts 01655
Questions or Comments? Email: publicaffairs@umassmed.edu Phone: 508-856-1572